Endeavour Group exits wineries in $300M overhaul
Endeavour Group (ASX:EDV) unveiled a strategic overhaul that will see the company exit the majority of its winery and vineyard portfolio.

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.
Endeavour Group (ASX:EDV) unveiled a strategic overhaul that will see the company exit the majority of its winery and vineyard portfolio.
Web Travel Group (ASX:WEB) secured a 20% rise in both total transaction value and revenue, reaching $5.8 billion and $394.1 million, respectively.
Kyivstar Group (NASDAQ:KYIV) announced the acquisition of six solar power plants in Ukraine’s Lviv region for a total consideration of UAH 3.6 billion (approximately $80.8 million), accelerating the telecommunication firm’s vertical integration into sovereign power generation to mitigate localized infrastructure risks.
Virax Biolabs Group (NASDAQ:VRAX) announced positive preliminary performance metrics from an early pilot dataset for ViraxImmune™, its proprietary blood-based diagnostic test under development for Long COVID and related post-acute infection syndromes (PAIS).
iQSTEL (NASDAQ:IQST) reported a 69.9% surge in consolidated revenue for the first quarter of 2026, driven by consistent volume expansion across its core telecommunications subsidiaries and an increasingly meaningful operational lift from its newly integrated fintech assets.
Eli Lilly (NYSE:LLY) announced an aggressive expansion into the infectious disease prevention sector, entering into definitive agreements to acquire three distinct vaccine developers for a combined potential value of up to $3.83 billion in cash.
Northern Oil and Gas (NYSE:NOG) agreed to acquire an undivided 25% non-operated interest in light oil assets within Alberta’s Duvernay Shale for an initial unadjusted purchase price of CA$350 million (approximately US$259 million), marking the company’s first expansion outside of the United States.
Sunlands Technology Group (NYSE:STG) preserved its four-year streak of consecutive quarterly profitability during the first quarter, relying on aggressive structural cost-cutting to mitigate a slide in net revenues and new student enrollments.
Noxopharm (ASX:NOX) shares surge on data showing its proprietary Sofra platform can amplify immune cells to actively fight cancer.
Worley (ASX:WOR) secures a key engineering and design contract from American Electric Power for a 450MW gas turbine project.